Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1252-1256

  Ahogo, C K ^a   Ezzedine, K ^a,b   Prey, S ^a,b   Colona, V ^a   Diallo, A ^a   Boralevi, F ^a,b   Taieb A ^a,b   Leaute Labreze C ^a  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL; ANTINEOPLASTIC AGENT;

ARTICLE; CAPILLARY HEMANGIOMA; CHILDHOOD DISEASE; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; PHOTOGRAPHY; PRIORITY JOURNAL; RELAPSE; RESIDUAL VOLUME; RETREATMENT; RETROSPECTIVE STUDY; TELANGIECTASIA; TREATMENT DURATION; TREATMENT RESPONSE; CHILD; HEAD AND NECK NEOPLASMS; HEMANGIOMA; NEOPLASM RECURRENCE, LOCAL; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SKIN NEOPLASMS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PROPRANOLOL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84889010841     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12432     Document Type: Article

References (13)

1. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al,. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
2. Sans V, Dumas de la Roque E, Berge J, et al,. Propranolol for severe infantile hemangiomas: a follow-up report. Pediatrics 2009; 124: e423-31.
3. Holmes WJ, Mishra A, Gorst C, Liew SH,. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg 2011; 64: 445-51.
4. Bagazgoitia L, Hernández-Martín A, Torrelo A,. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 2011; 28: 658-62.
5. Price CJ, Lattouf C, Baum B, et al,. Propranolol versus corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 2011; 147: 1371-6.
6. Georgountzou A, Karavitakis E, Klimentopoulou A, et al,. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatr 2012; 10: e469-74.
7. Léauté-Labrèze C, Prey S, Ezzedine K,. Infantile haemangioma: part II: Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011; 25: 1254-60.
8. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-74.
9. Chang LC, Haggstrom AN, Drolet BA, et al,. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008; 122: 360-7.
10. Hess CP, Fullerton HJ, Metry DW, et al,. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. Am J Neuroradiol 2010; 31: 1980-6.
11. Drolet BA, Frieden IJ,. Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch Dermatol 2010; 146: 1295-9.
12. Happle R,. Superimposed segmental hemangioma of infancy. Dermatology 2010; 220: 180-2.
13. Suh KY, Frieden IJ,. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol 2010; 146: 971-6.